Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Total Non-Current Liabilities (2022 - 2023)

Historic Total Non-Current Liabilities for iBio (IBIO) over the last 2 years, with Q3 2023 value amounting to $24.2 million.

  • iBio's Total Non-Current Liabilities changed N/A to $24.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $24.2 million, marking a year-over-year change of. This contributed to the annual value of $25.3 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q3 2023, iBio's Total Non-Current Liabilities is $24.2 million.
  • iBio's 5-year Total Non-Current Liabilities high stood at $31.9 million for Q4 2022, and its period low was $24.2 million during Q3 2023.